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Timing and number of minor infections as
risk factors for childhood arterial ischemic
stroke
ABSTRACT
Objective: In a population-based case-control study, we examined whether the timing and number
of minor infections increased risk of childhood arterial ischemic stroke (AIS).
Methods: Among 102 children with AIS and 306 age-matched controls identified from a cohort of
2.5 million children in a large integrated health care plan (1993–2007), we abstracted data on all
medical visits for minor infection within the 2 years prior to AIS or index date for pairwise age-
matched controls. We excluded cases of AIS with severe infection (e.g., sepsis, meningitis). Using
conditional logistic regression, we examined the effect of timing and total number of minor
infections on stroke risk.
Results: After adjusting for known pediatric stroke risk factors, the strongest association between
infection and AIS was observed for infectious visits#3 days prior to stroke (odds ratio [OR] 12.1,
95% confidence interval [CI] 2.5, 57, p 5 0.002). Respiratory infections represented 80% of
case infections in that time period. Cases hadmore infectious visits, but not significantly so, for all
time periods $4 days prior to the stroke. A greater cumulative number of infectious visits over
2 years did not increase risk of AIS.
Conclusions: Minor infections appear to have a strong but short-lived effect on pediatric stroke
risk, while cumulative burden of infection had no effect. Proposed mechanisms for the link
between minor infection and stroke in adults include an inflammatory-mediated prothrombotic
state and chronic endothelial injury. The transient effect of infection in children may suggest a
greater role for a prothrombotic mechanism. Neurology® 2014;83:890–897
GLOSSARY
AIS 5 arterial ischemic stroke; CI 5 confidence interval; ICD-9 5 International Classification of Diseases, 9th revision;
KPNC 5 Kaiser Permanente Northern California; KPSS 5 Kaiser Pediatric Stroke Study; OR 5 odds ratio.
A minority of children with established stroke risk factors (e.g., congenital heart disease) ever has
an arterial ischemic stroke (AIS),1 suggesting that childhood AIS is multifactorial and potentially
affected by environmental risk factors. Exposure to minor infection is both pervasive throughout
childhood and linked to AIS in adults.2–8
Minor infection may affect stroke risk either through systemic effects of inflammatory medi-
ators causing a prothrombotic state or by direct or indirect effects on arteries through various
mechanisms.3 Several studies suggest that minor acute infection can trigger stroke in adults,
particularly young adults.6,8–13 Infectious burden, the cumulative exposure to multiple infections
over time as measured by laboratory assays, exacerbates atherosclerosis14–19 and increases stroke
risk in adults.20,21 Children have negligible atherosclerosis and less time to accumulate chronic
effects of infection, but are commonly exposed to minor acute infections. We hypothesized
that minor infection can trigger childhood stroke, while cumulative number has less effect.
In a recent population-based case-control study exploring risk factors for childhood AIS, we
found that a medical visit for infection in the prior 28 days increased risk.7 However, we lacked
data to assess the effect of timing or the effect of multiple infections. For the current study, we
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collected detailed data on infectious exposures
in the preceding 2 years to determine the effect
of timing, duration, and cumulative number
of minor infections on childhood stroke risk.
METHODS The methods of case and control ascertainment
for this nested case-control study, part of the Kaiser Pediatric
Stroke Study (KPSS), have been previously described7; for the
current study, we performed additional chart abstraction on the
same childhood AIS cases and controls drawn from the study
cohort of 2.5 million children (.28 days and #19 years of
age) enrolled in Kaiser Permanente Northern California
(KPNC), 1993–2007 (figure 1). We included only strokes that
occurred between 29 days and #19 years, excluding any strokes
assumed to occur perinatally but diagnosed after the perinatal
period. Because our focus was minor infections, the current
analyses excluded all cases with a preceding (prior 4 weeks) or
concurrent diagnosis of major infections associated with stroke
(meningitis, sepsis, or endocarditis) and their matched controls.
Setting. KPNC, the largest nonprofit managed care organization
in the United States, encompasses 21 hospitals and 36 outpatient
facilities, serves approximately 30% of the people in Northern
California, and is largely representative of that population except
at the outlying socioeconomic extremes.22
Case ascertainment and confirmation. We have previously
described the methodology used to identify and confirm AIS
cases.7,23,24 We searched inpatient and outpatient electronic data-
bases for diagnoses indicative of stroke including ischemic stroke
(ICD-9 codes 433–436, 437.6, and 325), subarachnoid hemor-
rhage (ICD-9 codes 430 and 772.2), and intracerebral hemor-
rhage (ICD-9 code 431). We also performed text string searches
of all head imaging reports (MRI and CT) using the following
Figure 1 Identification of study cases and controls
Flow diagram demonstrates how study cases and controls were identified within the cohort of 2.5million children enrolled in
Kaiser Permanente Northern California from 1993 through 2007. AIS 5 arterial ischemic stroke.
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text strings: stroke, infarct, infarction, infarcted, thrombus,
thromboembolic, thromboembolism, thrombotic, thrombosis,
ischemia, ischemic, lacune, lacunar, vascular event, porencephaly,
and porencephalic. A single pediatric stroke neurologist (H.J.F.)
reviewed identified reports.24 Traditional (paper) and electronic
medical records of potential stroke patients were reviewed by 2
neurologists to confirm AIS using pre-established clinical and
radiographic criteria, with arbitration by a third. Criteria
included (1) documented clinical presentation consistent with
stroke, such as a sudden onset focal neurologic deficit; and (2)
CT or MRI showing a focal ischemic infarct in a location and of a
maturity consistent with the neurologic signs and symptoms. We
excluded cases if the stroke occurred prior to the child’s Kaiser
enrollment or outside of the study period.24
Control selection. Three population-based controls per case
were randomly selected from the study cohort and matched on
age, year of KPNC enrollment, and primary care facility. Each
control was assigned the stroke date of the matched case, which
was used as an index date for the purpose of collecting control
data on infectious visits occurring prior to stroke.
Data abstraction. A single pediatric RNmedical records analyst
abstracted data through review of electronic and traditional med-
ical records for both cases and controls. Previously examined
KPSS data included only a dichotomous classification of a visit
for infection within the 28 days prior to stroke diagnosis.7 For
the current study, the analyst abstracted detailed data regarding all
documented medical visits specifically for infectious illnesses in
the 2 years prior to the stroke/index date.
Classification of primary stroke etiology. In our historical
cohort, we were limited by the fact that many early cases did
not receive what would today be considered a complete stroke
evaluation; contemporary childhood stroke classification systems
could not be applied. We therefore used a simple construct for
etiology, based on data in the medical record indicating the pres-
ence of comorbidities that increase the risk of childhood stroke. A
single pediatric stroke neurologist (H.J.F.) reviewed all available
records to identify broad categories of potential etiology: cardiac
disease, major infection such as meningitis and sepsis (all excluded
from this study), hypercoaguable state, primary arteriopathy (with
subtypes based on imaging reports since actual imaging studies were
not available for review), sickle cell disease, and cancer. We defined
as idiopathic strokes in children with no documented comorbidities
suggestive of increased susceptibility.24 In the current study, we
adjusted for the presence of these factors to control for potential
confounding. When comorbidities were not documented in the
records, we assumed that they were absent.
Analyses of timing of infection. Data collection focused on
the 2 years prior to stroke/index date; children whose strokes
occurred before age 2 (and their controls) had less time to accumu-
late infections. Analyses of specific time periods included only those
who had accrued the requisite amount of time. Children could have
infections during multiple time periods; therefore, analyses of infec-
tions diagnosed during a specific time period were adjusted for infec-
tions during all other time periods, effectively holding them
constant. Binary variables were created for infection occurring during
the following distinct time periods (in days): 0–3, 4–7, 8–30, 31–60,
61–90, 91–120, 121–150, 151–180, 181–360, and 361–720.
Cumulative number of infectious exposures. Because blood
samples were not available in this retrospective study, we could
not measure infectious burden as defined in adult studies using
serologic assays for common pathogens.20,21 Instead, we used as
a marker the total number of visits during the prior 2 years at
which a specific diagnosis of 1 or more infections was made.
Multiple visits for infection within 1 week were considered part
of the same infectious process, and therefore counted as a single
visit. We required that cases (and their matched controls) had a
length of at least 2 years of prior observation to be included in this
analysis and thus excluded children under 2 years of age.
Effect of vascular abnormalities. In the 72 children with AIS
who received vascular imaging (cerebral or cervical magnetic res-
onance angiography, CT angiography, or conventional angiogra-
phy), we examined whether infection increases risk of
arteriopathy, defined as a pathologic abnormality of a cerebral
or cervical artery described on the formal imaging report. A single
MD reviewer (H.J.F.) reviewed the reports, blinded to history of
infection, to determine presence of arteriopathy.
Statistical analysis. All analyses were conducted using condi-
tional logistic regression to account for matching. Infection-
related predictors were examined in models (as described above)
adjusting for other time periods. Additional multivariable models
were also adjusted for risk factors known to be associated with
childhood stroke: sex; chronic conditions (e.g., autoimmune
disease, cardiac disease, and hematologic disease); and preceding
head or neck trauma (as previously defined).7 All analyses were
done using Stata v12 (Stata Corp., College Station, TX).
Standard protocol approvals, registrations, and patient
consents. Study procedures were approved by the institutional
review boards at KPNC and the University of California, San
Francisco; consent was waived for this retrospective study.
RESULTS Our study included 102 children diag-
nosed with AIS, without a preceding or concurrent
major infection, and 306 age-matched controls
(figure 1). Primary comorbid factors that may have
contributed to stroke etiology included cardiac disease
(n5 12), hypercoaguable conditions (n5 10), primary
arteriopathy (n 5 45, including diagnoses of arterial
dissection, n 5 8, and moyamoya, n 5 9), sickle cell
disease (n 5 2), and leukemia or lymphoma (n 5 3).
Six children had had a recent head or neck trauma
without receiving a diagnosis of dissection. The
strokes were idiopathic in the remaining 29 children.
A total of 74 cases (73%) and 187 controls (61%) had at
least 1 visit for infection during the 2-year observation
period; allowing for multiple visits per child, the 261
study subjects accrued a total of 969 visits with an
infection diagnosis. Analyses requiring the full 2 years
of prior data included 81% of the study subjects: 83
cases and 249 controls (table 1; model 1). All children
had at least 1 month of data prior to stroke/index date,
and could be included in analyses of this time period
(table 1; model 2).
Timing of infection. Rates of infection prior to stroke/
index date were greater for cases than controls in each
time period (table 1). Excluding children with fewer
than 2 years of data and adjusting for all time periods
(model 1), only a visit for infection within 3 days
increased risk of stroke. In an analysis focused on
the month prior to stroke and including all children
(model 2), the risk again appeared to be concentrated
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in the most proximate time period. These recent in-
fections occurred in children across the age spectrum
(figure 2A). When we adjusted for other childhood
stroke risk factors (table 2), a diagnosis of infection 3
days prior remained an independent risk factor, con-
ferring a 12-fold increased risk of AIS.
Our 102 cases included 3 children with a prior
stroke that occurred either before the study period or
before enrollment in KPNC.We conducted a sensitiv-
ity analysis of infection in the prior 3 days as a predic-
tor of first stroke by excluding these 3 cases and their
controls, and adjusting for the same variables as in
the primary multivariable model (table 2): the OR
was 10.7 (95% CI 2.2, 51, p 5 0.003), compared
to 12.1 in the primary analysis.
Cumulative number of infectious exposures. We com-
pared the total number of visits for infection in the
2 years preceding the stroke/index date between
cases and controls with at least 2 years of prior
observation time (figure 2B). When adjusted for
the timing of these infections, the cumulative num-
ber of infectious exposures did not increase stroke
risk (table 1).
Table 1 Demographics and infectious exposures among cases of childhood arterial ischemic stroke (without
major infection) and age-matched controls in Kaiser Permanente Northern California, 1993–2007
Characteristic
Cases (n 5 102),
n (%)
Controls (n 5 306),
n (%)
Logistic regression
OR (95%) CI p Value
Age, y, median (IQR) 11.6 (3.4, 17.2) 11.6 (3.2, 17.2)
Male 56 (54.9) 159 (52.0) 1.1 (0.7, 1.8) 0.63
Race
White 47 (46.1) 127 (41.5) Ref
Black 13 (12.7) 34 (11.1) 1.1 (0.5, 2.3) 0.85
Hispanic 18 (17.6) 44 (14.4) 1.1 (0.6, 2.1) 0.78
Asian 16 (15.7) 30 (9.8) 1.4 (0.7, 3.0) 0.33
Timing of infection
Model 1a,b
£3 days prior to strokec 6/83 (7.2) 2/249 (0.8) 8.3 (1.6, 42) 0.01
4–7 days prior to strokec 3/83 (3.6) 1/249 (0.4) 7.8 (0.8, 79.4) 0.08
8–30 days prior to stroke 7/83 (8.4) 10/249 (4.0) 1.6 (0.5, 4.9) 0.41
2–3 months prior to stroke 14/83 (16.9) 28/249 (11.2) 1.5 (0.6, 3.3) 0.37
4–6 months prior to stroke 18/83 (21.7) 44/249 (17.7) 1.1 (0.6, 2.3) 0.74
7–12 months prior to stroke 30/83 (36.1) 79/249 (31.7) 1.1 (0.6, 1.9) 0.85
1–2 years prior to stroke 35/83 (42.2) 101/249 (40.6) 0.8 (0.5, 1.5) 0.55
Model 2a,d
£3 days prior to strokec 10/102 (9.8) 2/306 (0.7) 15.0 (3.3, 68) ,0.0001
4–7 days prior to strokec 4/102 (3.9) 3/306 (1.0) 4.0 (0.9, 17.9) 0.08
8–30 days prior to stroke 10/102 (9.8) 27/306 (8.8) 1.0 (0.4, 2.6) 0.92
Number of infectionsb
Total visits for infection in 2 years prior to
stroke, median (IQR)
1 (0, 3) 1 (0, 4)
Unadjusted 1.1 (1.0, 1.2) 0.06
Adjusted for infection in all specific time periods 1.0 (0.9, 1.2) 0.62
Adjusted for infections within 1 month prior to
stroke
1.0 (0.9, 1.2) 0.52
Adjusted for infections within 1 month and
chronic risk factors
0.9 (0.8, 1.1) 0.43
Abbreviations: CI 5 confidence interval; IQR 5 interquartile range; OR 5 odds ratio.
aModel adjusted for each individual time period.
b Logistic regression excludes cases with fewer than 2 years of data and their controls.
c Repeat visits within 1 week were considered part of the same infection, and therefore counted as a single visit.
d Logistic regression includes all 102 cases and 306 controls.
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Type of infection. The most frequently diagnosed in-
fections over the observation period were upper respi-
ratory in both cases and controls (table 3). Respiratory
infections accounted for 8 of the 10 case infections in
the 3 days prior to stroke; only 2 cases (1 with upper
respiratory infection, 1 with pneumonia) had been
admitted to the hospital. Seven of the 8 cases with
respiratory infections had vascular imaging, but none
received a diagnosis of arterial dissection.
Association of infection with arteriopathy. Of 72 cases
with vascular imaging data, 28 (39%) had an imag-
ing report consistent with a cerebral or cervical arte-
riopathy; 17 had a specific diagnosis of moyamoya
(n 5 9) or arterial dissection (n 5 8), while the
others had arterial abnormalities without a specific
diagnosis. We observed no difference in the rate or
timing of infections prior to stroke between those
with and without arteriopathy. Within 3 days prior,
11% of those with arteriopathy vs 14% of those
without arteriopathy were diagnosed with a minor
infection (p 5 1.00); within 7 days prior, 11% vs
18% (p 5 0.51); within 30 days prior, 14% vs 27%
(p 5 0.25). Likewise, the total sum of infectious
visits over 2 years did not differ: median (interquar-
tile range) visits were 1 (0, 4.5) for cases with arte-
riopathy; 1 (0, 4) for those with no arteriopathy; and
2 (0, 4) for those with no vascular imaging (p 5
0.83, Kruskal-Wallis test).
Figure 2 Minor infections preceding childhood arterial ischemic stroke
(A) Recent minor infection by age at stroke. Proportion of childhood arterial ischemic stroke cases (n 5 102) with a visit
for minor infection within 3 days prior to stroke, stratified by age group. (B) Number of infection visits in prior 2 years.
Cumulative number of visits for minor infection in the 2-year period prior to stroke/index date in cases of childhood arterial
ischemic stroke (n5 83) and age-matched controls (n5 249). Repeat visits within 1 week were considered part of the same
infection, and therefore counted as a single visit.
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DISCUSSION In our prior study of this population-
based cohort, a medical visit for minor infection in
the preceding 4 weeks was a risk factor for
childhood AIS, even after adjusting for chronic
diseases that increase stroke risk and could lower
the threshold for seeking medical attention.7 In the
current report, we further explore infection as a risk
factor for stroke, and find that (1) elevated stroke risk
after infection may be transient, lasting only a few
days; (2) the cumulative number of infections over
time does not appear to play a role in stroke risk; and
(3) respiratory infections are the most common type
of infection immediately preceding childhood AIS.
Prior studies examining acute infection and adult
AIS have typically assessed a single time window for
exposure, ranging from 1 to 8 weeks before the
stroke.6,9,11,25 Most of these studies used broad defi-
nitions of acute infection including bacterial and viral
etiologies and any system involvement. Overall, the
ORs for the association with AIS ranged from 2.9
(95% CI 1.6–5.3) for an infection in the prior 2
months (although 93% of the case infections
occurred in the week prior to stroke)11 to 4.5 (95%
CI 2.1–9.7) for an infection in the prior week.6 The
OR was larger in younger patients, suggesting that
infection is a more important risk factor in the
young.9 Indeed, the largest OR was observed in
young adults (,50 years old) with infection in the
prior month: 14.5 (95% CI 1.9–112) after adjust-
ment for traditional stroke risk factors.13 The associ-
ation between infection and stroke did not depend on
type of infection, suggesting that it is the infectious/
inflammatory state, rather than a specific pathogen,
that increases risk.
In our prior study of childhood AIS, the OR for
the association with infection in the preceding 4
weeks, adjusted for chronic disease diagnoses, was
4.6, similar to reports from adult studies.7 However,
in the current study, when we further assessed the role
of timing of infection, we found that the period of
highest risk is the 3 days after a visit for infection: OR
12.1 (95% CI, 2.5, 57). The risk rapidly diminishes
after this period, with no increased risk of stroke
beyond 1 week. One adult study examined timing
of infection using within-person comparisons, and
similarly found that risk of stroke was highest within
the first 3 days after an infectious encounter, although
their reported relative risk was lower (incidence ratio
3.2, 95% CI 2.8–3.6).10 This suggests that infection
has an acute and powerful effect on stroke risk that is
transient, wanes quickly over days, and may be more
robust in children than adults. Our study cannot rule
out, however, a more modest but persistent effect of
infection on stroke risk: cases had more visits for
infection than controls in all time periods up to 2
years, and the lack of significance could be due to
inadequate power to detect a modest effect.
Overall, the spectrum of minor infections was
remarkably similar between cases and controls. Among
infections in the prior 3 days, the period of greatest
risk, respiratory infections predominated among the
stroke cases. This is consistent with studies of acute
infection and stroke risk in adults, which similarly
did not point to a particular organism, but consistently
found respiratory infections the most common, com-
prising 41%–80% of all recent infections.6,8,11–13
Studies of atherosclerosis in adults have suggested a
role for infectious burden leading to a chronic inflam-
matory condition that exacerbates atherosclerosis and
Table 2 Multivariable analysis of minor infections within specific time periods
prior to stroke/index date in 102 cases of childhood arterial ischemic
stroke and 306 age-matched controlsa
Specific time period prior to stroke OR (95%) CI p Value
Infection within 3 days 12.1 (2.5, 56.7) 0.002
Infection from 4 to 7 days 2.7 (0.5, 14.9) 0.24
Infection 8–30 days 0.7 (0.2, 2.2) 0.60
Abbreviations: CI 5 confidence interval; OR 5 odds ratio.
a Adjusted for sex; immunologic, hematologic, and cardiac disease; and head or neck trauma
in the preceding month.
Table 3 Specific minor infection diagnoses in cases of childhood arterial
ischemic stroke and their age-matched controls in the 2 years
preceding stroke/index date
Infection diagnosis
Cases (n 5 102), n (%) Controls (n 5 306), n (%)
Prior 2 years Prior 3 days Prior 2 years Prior 3 days
Upper respiratory infection 50 (49.0) 6 (5.9) 139 (45.4)
Viral syndrome 30 (29.4) 56 (18.3)
Otitis media 29 (28.4) 1 (1.0) 82 (26.8) 1 (0.3)
Conjunctivitis 16 (15.7) 24 (7.8)
Gastroenteritis 15 (14.7) 1 (1.0) 33 (10.8)
Pneumonia 12 (11.8) 2 (2.0) 12 (3.9)
Exanthema 11 (10.8) 9 (2.9)
Sinusitis 10 (9.8) 25 (8.2)
Urinary tract 4 (3.9) 16 (5.2) 1 (0.3)
Cellulitis 3 (2.9) 4 (1.3)
Chicken pox 3 (2.9) 4 (1.3)
Other skin 2 (2.0) 11 (3.6)
Abscessa 1 (1.0) 2 (0.7)
Tonsillitis 1 (1.0) 9 (2.9)
Flu 0 1 (0.3)
Chlamydia 0 1 (0.3)
Epstein-Barr syndrome 1 (1.0) 3 (1.0)
Herpes simplex type 1 1 (1.0) 2 (0.7)
Herpes simplex type 2 0 1 (0.3)
a Primarily dental abscess; no child had a cerebral abscess.
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increases stroke risk.3,26 In these studies, infectious bur-
den is typically defined as the number of positive se-
rologies to common pathogens, reflecting both clinical
and subclinical infections. Without access to blood
samples, we assessed the cumulative total medical visits
for infection over the preceding 2 years, but did not
detect a greater risk of childhood AIS with increased
visits. Since we were unable to perform serologies, we
cannot rule out an increased risk due to infectious
burden as defined in adult studies. However, our re-
sults may suggest that repeated exposure to infection
over time is less important for the pathogenesis of
childhood than adult stroke.
Our findings may shed some light on the potential
causal pathway between minor infection and childhood
AIS. The transient nature of the risk seems more con-
sistent with infection-related activation of the coagula-
tion cascade, rather than arterial injury. (We observed
similar rates of recent infection in stroke cases with
and without arteriopathy, but we may have been under-
powered to assess this.) Alternative explanations include
exposure to cold remedies containing vasoactive medi-
cations and mechanical forces from coughing or sneez-
ing leading to cervical arterial dissection; although we
did not observe recent respiratory infections in the small
number of dissection cases in this study, these mecha-
nisms could also plausibly cause a short-lived increase
in stroke risk. Infection in childhood is exceedingly
common, while AIS is not; we hypothesize that infec-
tion may act as a trigger in a child who is otherwise pre-
disposed to stroke.
Study limitations include its retrospective nature,
which precluded measurement of precise timing of
infection onset or exposure to over-the-counter med-
ications. Defining infections by medical visits likely
underestimates actual infectious exposure, although
this should not differ between cases and controls after
adjustment for chronic disease. Although the medical
records analyst was unblinded to case/control status,
we defined medical visit for infection as objectively
and broadly as possible by specifying a list of key
words to identify an infection-related visit. Serologic
assays were infrequent; infections were identified by
physician diagnosis alone. The Kaiser population lacks
socioeconomic extremes, although infectious exposures
may be higher in children of low socioeconomic status.
The unavailability of vascular imaging for centralized
review precluded meaningful analyses of the role infec-
tion might play in the presence of arteriopathy. How-
ever, advantages of our study are that it is population-
based, and therefore not subject to referral bias, and
that our measure of infection was resistant to recall bias.
An ongoing 40-center NIH-funded prospective
study, Vascular effects of Infection in Pediatric
Stroke, overcomes many of these limitations by col-
lecting vascular imaging for consistent classification
of arteriopathies and blood samples for objective mea-
surement of infectious exposure.27 This large interna-
tional effort will shed further light on the role of
infection in childhood AIS.
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Do You Need Funding—and Protected Time—for
Your Research?
With the current crisis in the lack of available research funding, the American Brain Foundation 2015
Clinical Research Training Fellowships offer a unique opportunity to receive funding—and much-
needed protected time—to conduct your research into causes, treatments, preventions, or cures for
brain disease. The deadline to apply is October 1, 2014—visit AAN.com/view/fellowships2015 today!
Save These Dates for AAN CME Opportunities!
Mark these dates on your calendar for exciting continuing education conferences by the American
Academy of Neurology. Learn more at AAN.com/conferences.
AAN Fall Conference
• October 31-November 2, 2014, Las Vegas, NV, The Cosmopolitan of Las Vegas
AAN Annual Meeting
• April 18-25, 2015, Washington, DC, Walter E. Washington Convention Center
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